MedVellum
MedVellum
Back to Library
Neurology
Neurosurgery

Normal Pressure Hydrocephalus

Moderate EvidenceUpdated: 2025-12-22

On This Page

Red Flags

  • Rapid neurological deterioration
  • Signs of raised ICP
  • Acute gait deterioration with falls
  • New incontinence with confusion
Overview

Normal Pressure Hydrocephalus

1. Overview

Normal Pressure Hydrocephalus (NPH) is a potentially reversible cause of dementia characterized by ventricular enlargement with normal or intermittently elevated CSF pressure. It accounts for approximately 5% of all dementia cases and is uniquely treatable with CSF shunting.

The Hakim-Adams Triad

The classic clinical presentation includes three cardinal features:

  1. Gait Disturbance (earliest and most responsive to treatment)

    • Magnetic gait - feet appear "stuck to the floor"
    • Broad-based, shuffling steps
    • Reduced stride length and height
    • Difficulty initiating walking
    • Postural instability with frequent falls
  2. Cognitive Impairment (subcortical pattern)

    • Psychomotor slowing
    • Executive dysfunction
    • Memory impairment (less prominent than Alzheimer's)
    • Apathy and inattention
  3. Urinary Incontinence (latest to appear)

    • Initially urinary urgency and frequency
    • Progresses to frank incontinence
    • May have fecal incontinence in advanced cases

Mnemonic: "Wet, Wacky, Wobbly"

  • Wet = Urinary incontinence
  • Wacky = Cognitive impairment
  • Wobbly = Gait disturbance

Key Epidemiology

FactorDetails
AgePeak incidence >0 years
Prevalence1-2% of those >5 years
GenderMales slightly more affected
TypesIdiopathic (iNPH) most common in elderly

2. Pathophysiology
┌─────────────────────────────────────────────────────────────────────────────┐
│                    NPH PATHOPHYSIOLOGY FLOWCHART                            │
├─────────────────────────────────────────────────────────────────────────────┤
│                                                                             │
│   ┌─────────────────────────────────────────────────────────────────────┐   │
│   │                      TRIGGERING FACTORS                             │   │
│   │  • Prior SAH, Meningitis, Head Trauma (Secondary NPH)               │   │
│   │  • Age-Related Changes in CSF Dynamics (Idiopathic NPH)             │   │
│   │  • Reduced CSF Absorption at Arachnoid Granulations                 │   │
│   └─────────────────────────────────────────────────────────────────────┘   │
│                                    ↓                                        │
│   ┌─────────────────────────────────────────────────────────────────────┐   │
│   │               VENTRICULAR DILATION                                  │   │
│   │  • CSF accumulation with pressure transmission                      │   │
│   │  • Stretching of periventricular white matter fibers                │   │
│   │  • Corpus callosum and corona radiata affected                      │   │
│   └─────────────────────────────────────────────────────────────────────┘   │
│                                    ↓                                        │
│   ┌─────────────────────────────────────────────────────────────────────┐   │
│   │              PERIVENTRICULAR WHITE MATTER DAMAGE                    │   │
│   │  • Descending motor fibers to legs (gait)                           │   │
│   │  • Frontal lobe connections (cognition)                             │   │
│   │  • Sacral motor fibers (bladder control)                            │   │
│   └─────────────────────────────────────────────────────────────────────┘   │
│                                    ↓                                        │
│        ┌──────────────────────┬──────────────────┬────────────────────┐     │
│        ↓                      ↓                  ↓                    │     │
│   ┌─────────┐          ┌─────────────┐    ┌───────────────┐          │     │
│   │  GAIT   │          │ COGNITIVE   │    │   URINARY     │          │     │
│   │APRAXIA  │          │ IMPAIRMENT  │    │ INCONTINENCE  │          │     │
│   └─────────┘          └─────────────┘    └───────────────┘          │     │
│                                                                       │     │
└─────────────────────────────────────────────────────────────────────────────┘

Key Pathophysiological Concepts

  • Normal Opening Pressure: Unlike obstructive hydrocephalus, CSF pressure is within normal range (10-18 cmH2O)
  • Intermittent Pressure Waves: B-waves may occur during sleep causing transient elevation
  • Ventricular Compliance: Progressive ventricular dilation compresses periventricular structures
  • Leg Motor Fibers: Located close to ventricles, hence early gait involvement

Idiopathic vs Secondary NPH

FeatureIdiopathic NPHSecondary NPH
CauseUnknownPrior meningitis, SAH, trauma
AgeElderly (>0)Any age
OnsetInsidiousMonths after insult
Shunt Response60-80%Often better if early

3. Clinical Features

History Taking

Essential Questions:

  • When did gait problems begin? (usually first symptom)
  • Has walking pattern changed? (shuffling, falls)
  • Memory or concentration problems?
  • Urinary urgency or accidents?
  • Any prior meningitis, head injury, or brain surgery?
  • Family history of dementia?

Gait Assessment

The gait disturbance in NPH is characteristic:

FeatureDescription
Magnetic gaitFeet appear glued to floor
Broad-basedWide stance for stability
Short strideReduced step length
ShufflingMinimal foot clearance
Turn difficultyMultiple steps to turn
Postural instabilityImpaired balance

Timed Up-and-Go (TUG) Test:

  • Patient rises from chair, walks 3 meters, turns, returns, sits
  • Normal: <10 seconds
  • NPH: Often >20 seconds
  • Useful for monitoring treatment response

Cognitive Profile

  • Subcortical pattern (unlike Alzheimer's cortical pattern)
  • Psychomotor slowing predominates
  • Executive dysfunction (planning, organization)
  • Frontal release signs may be present
  • Relatively preserved language and visuospatial skills

Physical Examination Findings

SystemFindings
GaitMagnetic, broad-based, shuffling
ToneParatonic rigidity (gegenhalten)
ReflexesMay have brisk lower limb reflexes
Frontal signsGrasp reflex, palmomental reflex
CognitionPoor attention, slow processing

4. Diagnosis

Diagnostic Criteria (International NPH Guidelines)

Probable iNPH:

  1. Insidious onset after age 40
  2. Duration >3-6 months
  3. Gait disturbance + at least one other triad feature
  4. Ventricular enlargement (Evans' index >0.3)
  5. No other condition explaining symptoms
  6. Positive CSF drainage test

Imaging Studies

MRI Brain (Gold Standard):

FindingSignificance
VentriculomegalyEvans' index >.3 (frontal horn width/biparietal diameter)
DESH signDisproportionately Enlarged Subarachnoid-space Hydrocephalus
Callosal angle<90° suggests NPH
Periventricular capsT2/FLAIR hyperintensity around ventricles
Aqueductal flow voidHyperdynamic CSF flow on MRI

Evans' Index Calculation:

  • Maximum width of frontal horns ÷ Maximum internal diameter of skull
  • Normal: <0.3
  • NPH: >0.3

CSF Dynamics Testing

Lumbar Puncture:

  • Opening pressure typically normal (10-18 cmH2O)
  • CSF analysis normal (rule out infection, hemorrhage)

Large Volume Lumbar Puncture (Tap Test):

  • Remove 30-50 mL CSF
  • Assess gait before and 1-4 hours after
  • Improvement suggests shunt-responsive NPH
  • Sensitivity ~50-60%, Specificity ~80%

Extended Lumbar Drainage (ELD):

  • External lumbar drain for 3-5 days
  • 10 mL/hour continuous drainage
  • More sensitive than single tap test
  • Sensitivity 80-90%

Infusion Test:

  • Measures CSF outflow resistance (Rout)
  • Rout >18 mmHg/mL/min suggests NPH
  • Requires specialized equipment

5. Management Algorithm
┌─────────────────────────────────────────────────────────────────────────────┐
│                    NPH MANAGEMENT ALGORITHM                                 │
├─────────────────────────────────────────────────────────────────────────────┤
│                                                                             │
│   SUSPECTED NPH (Hakim Triad + Ventricular Enlargement)                     │
│                          ↓                                                  │
│   ┌─────────────────────────────────────────────────────────────────────┐   │
│   │                    INITIAL WORKUP                                   │   │
│   │  • MRI Brain: Confirm ventriculomegaly, Evans' index &gt;0.3          │   │
│   │  • Exclude other causes: Alzheimer's, Parkinson's, vascular        │   │
│   │  • Cognitive testing: MMSE, MoCA                                    │   │
│   │  • Gait assessment: Timed Up-and-Go test                            │   │
│   └─────────────────────────────────────────────────────────────────────┘   │
│                          ↓                                                  │
│   ┌─────────────────────────────────────────────────────────────────────┐   │
│   │               LARGE VOLUME TAP TEST                                 │   │
│   │  • Remove 30-50 mL CSF via LP                                       │   │
│   │  • Assess gait at 1 hour and 24 hours                               │   │
│   │  • Repeat TUG test                                                  │   │
│   └─────────────────────────────────────────────────────────────────────┘   │
│                          ↓                                                  │
│              ┌──────────────────────────────────────┐                       │
│              │        IMPROVEMENT?                   │                       │
│              └──────────────────────────────────────┘                       │
│                    ↓ YES              ↓ NO                                  │
│   ┌──────────────────────────┐  ┌──────────────────────────────────────┐   │
│   │  SHUNT RESPONSIVE        │  │  EXTENDED LUMBAR DRAINAGE (ELD)      │   │
│   │  High probability        │  │  • 3-5 day continuous drainage       │   │
│   │  Proceed to shunt        │  │  • If improves → Shunt candidate     │   │
│   │  surgery                 │  │  • If no improvement → Poor candidate │   │
│   └──────────────────────────┘  └──────────────────────────────────────┘   │
│                    ↓                                                        │
│   ┌─────────────────────────────────────────────────────────────────────┐   │
│   │              VENTRICULOPERITONEAL SHUNT                             │   │
│   │  • Programmable valve preferred (adjustable pressure)              │   │
│   │  • Gravitational/anti-siphon device reduces overdrainage           │   │
│   │  • Post-op: Valve adjustments as needed                            │   │
│   └─────────────────────────────────────────────────────────────────────┘   │
│                          ↓                                                  │
│   ┌─────────────────────────────────────────────────────────────────────┐   │
│   │              FOLLOW-UP & MONITORING                                 │   │
│   │  • Gait, cognition assessment at 3, 6, 12 months                    │   │
│   │  • CT Head if new symptoms (subdural, shunt malfunction)           │   │
│   │  • Valve pressure adjustments as needed                             │   │
│   │  • Watch for complications: Subdural hematoma, infection           │   │
│   └─────────────────────────────────────────────────────────────────────┘   │
│                                                                             │
└─────────────────────────────────────────────────────────────────────────────┘

Surgical Treatment: VP Shunt

Ventriculoperitoneal (VP) Shunt:

  • Most common surgical intervention
  • Diverts CSF from lateral ventricle to peritoneal cavity
  • Programmable valves allow non-invasive pressure adjustments

Shunt Outcomes:

  • 60-80% show improvement
  • Gait improves most reliably
  • Cognition and continence less predictable
  • Best outcomes with early intervention

Shunt Complications

ComplicationIncidenceManagement
Subdural hematoma/hygroma2-17%Adjust valve to higher pressure
Infection5-10%Antibiotics ± shunt revision
Shunt malfunction20-30% over 10 yearsShunt revision
OverdrainageVariableProgrammable valve adjustment

Alternative: ETV (Endoscopic Third Ventriculostomy)

  • May be considered in some cases
  • Creates internal CSF pathway
  • Avoids shunt hardware and its complications
  • Less commonly used for iNPH

6. Differentiating from Similar Conditions

NPH vs Other Dementias

FeatureNPHAlzheimer'sVascular DementiaParkinson's
GaitEarly, magneticLateVariableFestinating
MemoryModerateSevere, earlyVariableModerate
ImagingVentriculomegalyAtrophyWhite matter changesNormal/mild atrophy
TremorAbsentAbsentAbsentPresent
Tap testPositiveNegativeNegativeNegative

NPH vs Parkinson's Disease

Both have gait disturbance but key differences:

FeatureNPHParkinson's
GaitMagnetic, broad-basedFestinating, narrow-based
TremorNoYes (rest tremor)
RigidityParatonicCogwheel
Levodopa responseNoYes
ImagingVentriculomegalyNormal/mild atrophy

7. Prognosis

Factors Predicting Good Shunt Response

FactorFavorableUnfavorable
Duration<6 months> years
Gait predominantYesNo
CauseSecondary (known)Idiopathic
Tap testPositiveNegative
ComorbiditiesFewExtensive vascular disease

Outcomes After Shunting

SymptomImprovement Rate
Gait70-90%
Cognition50-70%
Continence40-60%

Key Point: Earlier diagnosis and treatment leads to better outcomes. Delayed treatment allows irreversible white matter damage.


8. Complications

Disease Complications

  • Progressive immobility and falls
  • Aspiration pneumonia from dysphagia
  • Pressure ulcers
  • Urinary tract infections
  • Caregiver burden

Shunt Complications

ComplicationPresentationManagement
Subdural collectionHeadache, neurological declineValve adjustment, rarely drainage
Shunt infectionFever, wound erythemaAntibiotics, shunt removal
Shunt obstructionSymptom recurrenceShunt revision surgery
SeizuresPost-operativeAnticonvulsants

9. Special Considerations

Elderly Patients

  • Higher surgical risk but still benefit from shunting
  • Careful pre-operative optimization
  • Consider frailty assessment
  • Involve family in decision-making

Coexisting Conditions

Vascular Dementia:

  • May coexist with NPH
  • More extensive white matter changes on MRI
  • Shunt response less predictable

Parkinson's Disease:

  • May coexist with NPH
  • Differentiation important as treatments differ
  • Both may coexist requiring combined management

Anesthetic Considerations

  • Often elderly with comorbidities
  • Cognitive impairment affects consent process
  • Post-operative delirium risk
  • May need geriatric medicine input

10. Key Clinical Pearls

Exam-Focused Points

  1. Classic Triad Recognition: Wet, Wacky, Wobbly - but gait is usually first and most responsive
  2. Evans' Index: >0.3 on CT/MRI suggests ventricular enlargement
  3. Tap Test: 30-50 mL CSF removal with gait improvement suggests shunt response
  4. Magnetic Gait: Distinctive pattern - feet appear stuck to floor
  5. Distinguishing from Parkinson's: No tremor, no levodopa response, broad-based not narrow gait
  6. Treatment: VP shunt with programmable valve is definitive treatment
  7. Best Outcome Predictor: Short duration, gait predominant, positive tap test

Common Exam Scenarios

  • Elderly patient with progressive gait difficulty, urinary incontinence, and memory problems
  • MRI showing ventriculomegaly out of proportion to cortical atrophy
  • Gait improvement after large volume LP
  • Shunt complications (subdural collection, infection)

11. Patient Explanation

What is Normal Pressure Hydrocephalus?

"Your brain produces a fluid called cerebrospinal fluid (CSF) that normally flows around the brain and spinal cord and gets absorbed back into the bloodstream. In NPH, this fluid builds up in the ventricles - the hollow spaces inside the brain - causing them to enlarge and press on surrounding brain tissue.

This pressure causes three main problems:

  1. Walking difficulties - Your feet may feel 'stuck to the floor'
  2. Memory and thinking problems - Slowness in thinking and planning
  3. Bladder control problems - Urgency and sometimes incontinence

The good news is that NPH is one of the few treatable causes of these symptoms."

How is it Diagnosed?

"We diagnose NPH through:

  1. Brain scan (MRI) - Shows enlarged fluid spaces in the brain
  2. Lumbar puncture (tap test) - We remove some fluid and see if your walking improves

If you improve after the tap test, it's a good sign that permanently draining the fluid with a shunt will help."

What is the Treatment?

"The main treatment is a shunt - a thin tube placed under the skin that drains excess fluid from your brain to your abdomen where your body absorbs it naturally.

Modern shunts have adjustable valves that we can fine-tune without surgery using a special magnet if needed. About 70-80% of people see improvement, especially in walking."


12. Evidence & Guidelines

Key Guidelines

GuidelineOrganizationYearKey Points
iNPH GuidelinesJapanese NPH Society2021Diagnostic criteria, tap test protocol
EAN-ESO GuidelinesEuropean Academy of Neurology2023Imaging requirements, shunt indications
AAN Practice ParameterAmerican Academy of Neurology2005Diagnosis and management recommendations

Landmark Studies

SINPHONI Trial (2010):

  • Randomized trial of shunt surgery vs conservative management
  • Demonstrated significant improvement in shunted patients
  • Established basis for surgical intervention

SYGNAT Study (2023):

  • Large multicenter study on shunt outcomes
  • Confirmed long-term benefits of shunting
  • Identified predictors of good response

Evidence-Based Recommendations

RecommendationEvidence Level
MRI for diagnosisStrong
CSF tap testModerate
VP shunt for confirmed NPHModerate
Programmable valve useModerate
Extended lumbar drainage if tap test negativeWeak

13. References
  1. Williams MA, Relkin NR. Diagnosis and management of idiopathic normal-pressure hydrocephalus. Neurol Clin Pract. 2013;3(5):375-385.

  2. Mori E, et al. Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus: Second Edition. Neurol Med Chir (Tokyo). 2012;52(11):775-809.

  3. Hashimoto M, et al. Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study. Cerebrospinal Fluid Res. 2010;7:18.

  4. Relkin N, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3 Suppl):S4-16.

  5. Kazui H, et al. Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trial. Lancet Neurol. 2015;14(6):585-594.

  6. European Association of Neurosurgery. Guidelines for the Diagnosis and Treatment of Idiopathic Normal Pressure Hydrocephalus. 2022.

  7. Israelsson H, et al. Vascular risk factors in INPH: A prospective case-control study. Neurology. 2017;88(6):577-585.

Last updated: 2025-12-22

At a Glance

EvidenceModerate
Last Updated2025-12-22

Red Flags

  • Rapid neurological deterioration
  • Signs of raised ICP
  • Acute gait deterioration with falls
  • New incontinence with confusion

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines